Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Canesten Combi 500mg Pessary & 2% Cream – PA1410/039/001
- Enap 10mg Tablet – PA0711/028/002
- Fluzac 20mg Capsule – PA0711/110/001
- Lotanos 50mg Tablet – PA0711/123/003
- Miramel 0.088mg Tablet – PA0126/173/001
- Miramel 0.018mg Tablet – PA0126/173/002
- Propofol-Lipura 2% 20mg/ml Emulsion for injection or Infusion – PA0736/018/003
- Rispone 6mg Tablet – PA0711/106/005
- Telmisartan 20mg Tablet – PA0126/228/001
- Venex XL 37.5 mg Prolonged-release capsules – PA0126/285/001
- Zolmitriptan 2.5mg Orodispersible Tablet – PA1380/035/003
The following shortage has been resolved and supply has resumed to the Irish market:
- Angeliq 1mg/2mg Tablet – PA1410/013/001
- Blopress 4mg Tablet – PA2229/001/002
- Epanutin 300mg Capsule – PA0822/011/004
- Epanutin Ready Mixed Parenteral 250mg/5ml Solution for Injection or Infusion – PA0822011/006
- Genotropin Miniquick 1mg Powder and Solvent for Solution for Injection – PA0822/128/007
- Genotropin Miniquick 1.2mg Powder and Solvent for Solution for Injection – PA0822/128/008
- Letrozole 2.5mg Film Coated Tablet – PA0749/0185/001
- Levofloxacin 5mg/ml Solution for Infusion – PA1122/013/001
- Neotigason 25mg Capsule – PA1380/050/002
- Proscar 5mg Tablet – PA1286/017/001
- Rifadin 300mg Capsule – PA0540/066/002
- Sustiva 600mg Film Coated Tablet – EU/1/99/110/009
- Tevaquel 25mg Film coated Tablet – PA0749/060/001
- Ultiva 2mg Powder for Concentrate for Solution for Infusion – PA1691/032/002
- Vancomycin 1000mg Powder for Concentrate for Solution for Infusion – PA1122/008/002
- Xylocaine 10mg Delivered Dose Mucosal Spray – PA1691/028/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.